Aratana Therapeutics requests FDA approval for NOCITA®
Aratana Therapeutics, Inc., a pet therapeutics company that is dedicated to developing, licensing, and selling innovative biopharmaceutical products specifically for companion animals, recently sent an administration New Animal Drug Application (NADA) to the U.S. Food and Drug Administration (FDA) for its new NOCITA. Read More »